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Dynamics and Control of Covid-19:  
Comments by Two Mathematicians 
by Bernhelm Booß-Bavnbek (Roskilde, Denmark) and Klaus 
Krickeberg (Manglieu, France and Bielefeld, Germany) 
Since the Covid-19 pandemic is not over it may appear to be 
premature to draw some conclusions. However, it may be, as well, 
just in time to recapitulate some lessons we as mathematicians 
should have learned and are urged to apply now. Thus we are 
asking: why are the dynamics and control of Covid-19 most 
interesting for mathematicians and why are mathematicians 
urgently needed for controlling the pandemic? 
We shall first present our comments in a Bottom-up approach, i.e., 
following the events from their beginning as they evolved through 
time. They happened differently in different countries, and the 
main objective of this first part is to compare these evolutions in a 
few selected countries with each other. 
Still, there are some general features, which we present separately 
as we are used to do in mathematics. They include the history of 
certain epidemics which have influenced the reactions of people in 
many countries, and some basic mathematical tools. In addition 
there is a common factor, which one of the present authors (KK) 
has defined on the 12th March 2020 in an e-mail to a German 
health office: 
"The extension and evolution of Covid-19 in various countries and 
regions reflects the state of their health systems. This was for 
instance already very obvious in the case of Ebola." 
It is in fact the Public Health component of the health system that 
plays a crucial role. 
The second part of the article is not "country-oriented" but 
"problem-oriented". From a given problem we go "Top-down" to 
its solutions and their applications in concrete situations. We have 
organized this part by the mathematical methods that play a role 
in their solution. Here is an example where specially much 
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mathematics is needed: to develop a vaccine and the strategy for 
applying it without loosing sight of basic ethical principles. 
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BOTTOM-UP 
1. Prehistory 
In the following the gentle reader may consult when necessary the 
book [KPP] for the basic concepts of epidemiology. 
Demography as a mathematical subject area was already 
developed centuries ago well beyond its elementary beginnings. 
For a long time it remained the only mathematical tool in the study 
of the evolution of infectious diseases. Here is a famous early 
example. In China, India and Europe one tried to confer immunity 
against smallpox by infecting individuals slightly so they would 
contract a mild form of the disease and be immune afterwards. 
Some of them died by this procedure but in 1766 the Swiss 
mathematician Daniel Bernoulli showed by a demographical 
approach that the procedure would increase life expectancy if 
applied to everybody [DI1]. Nowadays evaluating the cost-
effectiveness of a public health measure is being done widely; it is 
based on methods of mathematical economy. 
The 19th Century saw the discovery of microorganisms as 
pathogens of many diseases and their study by mainly 
microbiological methods. The mathematical tools for following up 
an epidemic remained essentially demographical well into the 20th 
Century.  A few physicians suggested that every epidemic ends 
because there are finally not enough people left to be infected, 
which is a naïve predecessor to the mathematical-epidemiologic 
concept of Herd Immunity (see Sect. 8). Nevertheless even the 
abundant literature on the influenza pandemic of 1918-19, wrongly 
called Spanish Flu, discusses only two possible ways for its ending: 
better clinical treatment and mutations of the pathogen.  
Seen from a virological viewpoint the Spanish Flu was an extreme 
form of the so-called seasonal influenza. The virus which causes 
them can be one of a large variety, its genus being denoted by A, 
B, C or D, where some of them include several species. A is the 
most serious one; is has subtypes A(HxNy), x = 1,...,18 and y = 
1,...,11, where x and y represent proteins on the surface of the 
virus. The strategy for controlling the "normal" seasonal influenza 
epidemic is widely known even among laymen: identify the strain 
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of the virus in autumn, develop a vaccine as fast as possible, and 
vaccinate people thought to be at risk. Nevertheless the number of 
infections and of deaths by a seasonal influenza can be as high as 
those by some of the pandemics to be described now.  
The Spanish flu was due to A(H1N1). Pictures from that time show 
people wearing masks that resembled those used now. In the 
years 1957-58 another "digression" from seasonal influenza 
occurred, called the Asian Flu and caused by A(H2N2). It started in 
China and then became a pandemic, passing from neighbouring 
states through the UK and the USA. Estimations of the number of 
cases vary around 500 millions and of the number of deaths 
around 3 millions. Its beginnings looked much like those of the 
Spanish Flu but towards the end a vaccine became available, a 
predecessor to the ones being used now routinely against the 
seasonal flu.  
The Hong Kong influenza of 1968-69, generated by the virus 
A(H3N2), had similar characteristics and will not be described 
further. 
Parallel to the entering the scene of these and other epidemics, 
and partly motivated by them, basically new mathematical tools of 
public health emerged in the first part of the 20th Century, 
preceded by a few studies in the late 19th. They were twofold. The 
first tool was called a "statistical-mathematical model". Its aim is 
the study of the influence of factors, also called determinants, on 
the health of people. Such factors may for instance be a lack of 
hygiene or a polluted environment. A factor can also be a 
preventive or curative treatment by an immunization or a drug, 
respectively; in that case the main objective of a study is to 
estimate the efficacy of the treatment. Sampling plans are 
statistical-mathematical models of a different but related kind. 
They form the basis of sample surveys, which are being done in 
profusion about Covid-19, too, and not always very illuminating. 
The second tool is called "mathematical modelling of the evolution 
of an epidemic", or briefly "mathematical modelling". There are 
two kinds of it. First, one may aim at the epidemic curve, which is 
the cumulated number of cases up to a moment t as a function of 
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t . In that case mathematical modelling serves to estimate or 
predict this curve under various assumptions on the infectivity of 
infected subjects. Early predecessors are presented in [FIN], see 
Figure 1; the question whether the infectivity remains constant or 
decreases played already a role. Refined versions are still being 
used, in particular for Covid-19 (Sect. 7).  
 
 
Fig. 1 Early numerical simulation of an epidemic curve by J. Brownlee, 1907, 
discussed in [FIN] 
Second, one may build so-called compartmental models (Sect. 8). 
The first one, for measles, was published in 1889 by P.D. En'ko; 
see [DI2].  Around the year 1900 compartmental models for 
malaria appeared. Then in the 1920s new models for the evolution 
of measles in closed populations were defined and intensively 
studied. They became very influential because they displayed 
already many basic features that reappeared later in mathematical 
models of epidemics in other and more complex settings.  
Such tools found many applications. Dealing with large epidemics 
mathematically was no longer a matter of demography alone, 
although that continued to be the main tool for estimating number 
of cases and deaths. Statistical-mathematical models were 
employed to estimate the efficacy of antiviral drugs, for instance 
against HIV-infections, and the efficacy of various immunizations 
Covid-19                  Booß-Bavnbek &Krickeberg, 17 august 2020                                                     6 
including those against forms of influenza. Mathematical modelling 
of epidemics was used in planning strategies to eradicate 
smallpox, poliomyelitis, measles and perhaps others. The first 
articles on modelling influenza epidemics appeared in the scientific 
literature. Planning a vaccination strategy involves both statistical-
mathematical and mathematical models [HAl]. 
These roads to progress may have produced a general feeling of 
success in dealing with epidemics. Then in the period from 2002 to 
2019 a few events occurred that evoked memories of previous 
pandemics and undermined such believes.    
2. Unexpected Events 2002-2018 
In November 2002 the first SARS (Severe Acute Respiratory 
Syndrome) epidemic broke out. It was a zoonosis generated by 
the virus SARS-CoV-1, a strain of the species SARS-CoV. It was 
first identified in China and never spread much beyond the 
surrounding countries and Canada. In July 2003 it was declared 
eradicated after having caused 8,096 cases and 774 deaths. 
Similarly the Middle East Respiratory Syndrome (MERS), due to the 
corona virus MERS-CoV, lead to around 2,500 cases and 870 
deaths between 2012 and 2020. It was essentially concentrated on 
Saudi Arabia and, to a minor degree, on South Korea, with most 
infections happening around the years 2014 to 2015. Being a 
zonoosis carried largely by camels, it is also called the Camel Flu. 
Moreover a pandemic influenza invaded the world that resembled 
the Spanish Flu in several respects. Its pathogen was a new strain 
called A(H1N1)09 of the H1N1 influenza virus. Its origin is being 
debated; a likely hypothesis says that, being a zoonosis carried by 
pigs, it infected a human on a Mexican pig farm around January 
2009. It was therefore called Swine Flu or Mexican Flu. It spread 
from North America to the whole world and was declared 
"extinguished" in August 2010. Estimations of the number of 
infections and deaths vary enormously but there were apparently 
more cases and fewer deaths than by the Spanish flu. Accusations 
against WHO were raised about its handling of vaccines against 
the Swine Flu. 
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Finally another zoonotic influenza appeared, popularly called Bird 
Flu and in scientific language Highly Pathogenic Avian Influenza 
(HPAI). The main pathogen was an A(H5N1) influenza virus. It had 
been known long ago but reached a peak in the years 2013-2017. 
Whether there existed an airborne transmission from poultry to 
humans was a hotly debated question with obvious economic 
consequences. The Bird Flu spread widely over the whole world 
but the number of known human cases remained small, just over 
70. 
In addition to various forms of influenza and the epidemics 
generated by the corona virus SARS-CoV-1, SARS-CoV-2 or MERS-
CoV, other epidemics occurred. It is instructive to compare them 
with those just mentioned, applying in addition mathematical 
yardsticks. We shall restrict ourselves to Ebola epidemics. Their 
most widespread outbreak was the Western African Ebola virus 
epidemic from 2013 to 2016, which caused 28,646 cases and 
11,323 deaths. There is a fundamental difference in the evolution 
of a case of influenza or SARS-CoV-1 or SARS-CoV-2 on the one 
hand and of an Ebola case on the other, which leads to a basic 
difference in their mathematical modelling (Sects. 4 and 8). A 
carrier of an influenza or corona virus can transmit it to other 
persons well before the first symptoms appear, that is well before 
the end of the incubation period. A subject infected by Ebola will 
become infective only around the end of the incubation period. He 
(if it is a man) could then be immediately isolated together with 
his latest contacts in order to avoid further extension of the 
infection, provided that there is a health service nearby to do it. 
Therefore Ebola did not spread to countries that have a sufficiently 
dense primary health care network but it caused much suffering in 
countries that do not have it. The strategy of WHO to control the 
epidemic was wrong. It insisted on drugs and the search for a 
vaccine (which became available only in December 2019) but 
neglected primary health care. For the present purpose it would 
even have been most useful to rapidly train village health workers 
and "barefoot doctors" as it had been done decades ago. 
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3. Looking at some Countries  
Only very few countries profited from the experiences of these 
premonitory 18 years to prepare much in advance for a possible, 
and probable, new outbreak of an epidemic. Some others took 
appropriate measures only at the first signs of Covid-19, and many 
started planning when the epidemic had almost reached its zenith. 
We shall sketch some examples. For simplicity we shall always 
describe the result of the strategy of a country by indicating its 
cumulated numbers of confirmed cases and deaths around the 1st 
June 2020. Regarding the reliability of these data see Sects. 5 and 
6.  
We begin with those that had planned early. 
Taiwan: Already in 2004, the year after the SARS-epidemic 
outbreak, the government established the National Health 
Command Center (NHCC), which was to prepare the country for a 
possible new epidemic. From 2017 on it was headed by the 
popular Minister of Health, Chen Shih-chung, who had studied 
dentistry at the Taipei Medical College. The Vice-President of 
Taiwan from 2016 to 2020, Chen Chien-jen, had been Minister of 
Health from 2003 to 2005 after having studied human genetics, 
public health, and epidemiology at the National Taiwan University 
and the Johns Hopkins University in the USA, followed by 
research. Thus decisions about the control of Covid-19 were taken 
by politicians competent in matters of health including Public 
Health. 
Taiwan counts 23 million inhabitants and many of them travelled 
from and to China. From the 31st December 2019 on when WHO 
was notified of the epidemic in Wuhan all incoming flights from 
there were checked, followed by controls of passengers arriving 
from anywhere. An "Action Table" was produced in the period 
20th January to 24th February 2020, which listed 124 measures to 
be taken. The public obtained daily revised clear information by all 
existing means. "Contact tracing", which means repeated follow-
up of symptomatic persons, of confirmed cases and of all of their 
contacts, was rapidly established on the basis of the electronic 
health insurance card that everybody has. The virological PCR-
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tests used (Sect. 4) were already available and quarantines well 
organised. In late January rules about the wearing of masks were 
edited; a sufficient supply existed already. 
As a result 442 confirmed cases had been found and 7 deaths 
recorded up to the 1st June.  
Vietnam: The Vietnamese strategy resembles the Taiwanese one 
in almost all aspects, with the exception of contact tracing. A 
Steering Committee to deal with new epidemics existed within the 
Ministry of Health. It put into effect its plan right after the 23rd 
January when the first infected persons arrived at Vietnamese 
airports, among them a Vietnamese returning from the UK. All 
schools were closed on the 25th January, and since the 1st 
February everybody entering Vietnam must spend two weeks in 
quarantine.  
Other measures were imposed or relieved in accordance with the 
evolution of the epidemic, for instance a limited confinement or 
the wearing of masks. The Ministry of Health issued regular 
precise and clear information for the entire population by all 
available means including smartphones. In addition there is a 
personalized information system by so-called "Survival Guides" 
given to everybody. Every survival guide defines three categories 
of persons: F0: a confirmed case; F1: suspected to be infected or 
having had contact with an infected person; F2: having had 
contact with a person in F1. Each person is expected to find the 
category to which it belongs. The survival guide then provides 
printed information about what she or he must do as a function of 
her or his category, for example to submit to a test. Only PCR-
tests are being used. 
In contrast to Taiwan contact tracing does not use electronic tools. 
It is being done by the population itself, aided by the survival 
guides, together with a large number of well-trained members of 
the health services, for example university lecturers. 
At the end of 2019 Vietnam had 98,257,747 inhabitants. On the 
1st of June there had been 328 confirmed cases and 0 deaths. 
These data are based on a strong demographic section of the 
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"General Statistical Office" and on several Health Information 
Systems [KKR] and can hardly be contested. 
The preceding sketch of control measures in Taiwan and Vietnam 
has shown us the three main components of their epidemiologic 
side: contact tracing; lock-down, that is physical, or social, 
distancing in the wide sense including quarantine and border 
controls; wearing of masks. We may call this the "surveillance-
containment strategy". In addition there is the medical-clinical 
side, from primary health care such as general practitioners up to 
large hospitals. Its state is crucial to the number of deaths caused 
by the virus SARS-CoV-2. 
In contrast to Taiwan and Vietnam it seems that all other countries 
of the world were unprepared at the end of December 2019. A few 
of them took fairly systematic and strict measures that covered the 
entire population as soon as the first cases had declared 
themselves. For a quick overview see Figure 2. This was for 
example true for China at the end of January 2020, for Slovakia 
and Greece on the 27th and 28th February, for Austria on the 
10th March and for Denmark on the 12th March. An alternative 
Danish strategy, based on rigorous contact tracing and quarantine, 
but not implemented until now was argued for in [SIA]. 
Regarding the results the turbulent evolution in China is well 
known. In Denmark, with a population of 5.806 million, about 
12,000 cases had been confirmed and 593 deaths recorded, and 
the corresponding figures for Austria are 8.86 million people, 
16,979 cases and 672 deaths.  
The confrontation of Slovakia, a country of around 5.5 million 
inhabitants, with Greece, which counts 10.72 million people, is 
particularly striking because it makes visible the role of their 
physicians and hospitals. In Slovakia there were 1,528 confirmed 
cases and 28 deaths. The corresponding data for Greece are 3,058 
and 183. The relatively much higher number of fatalities in Greece, 
in spite of equally early reaction and almost the same number of 
cases per number of inhabitants, is no doubt due to the 
catastrophic state of its medical-clinical system caused mainly by 
the debt crisis from 2010 on. 
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Next we pass to a group of countries that reacted late and not 
systematically, applying the various measures in a haphazard way 
and only to part of the population. Here are some of them with 
their numbers of inhabitants in million, cumulated numbers of 
confirmed cases and numbers of fatalities: 
Table 1. Countries that reacted late and not systematically (numbers pr. 1 
June 2020) 
Country Inhabitants (mio) Confirmed cases Fatalities  
Belgium 11.46 59,348 9,606 
Spain 46.94 289,046 27,136 
Italy 60.36 235,561 34,043 
France 66.99 154,591 29,296 
Germany 83.02 187,000 8,831 
 
The relatively low number of deaths in Germany reflects mainly a 
sufficient medical-clinical system that could readily adapt itself to 
the epidemic. The opposite was true in France. There, about 
100,000 hospital beds had been eliminated in the period between 
1993 and 2018. An arbitrary strict "confinement" not determined 
by epidemiologic reasoning was imposed on the 17th March. 
Finally there are countries that decided to do nothing, at least for 
a long while. Their motivation, or pretext, was above all a belief in 
herd immunity (Sects. 1 and 8) according to which the epidemic 
would stop by itself. This was the strategy of Sweden, a country 
counting 10.23 million persons, which resulted in 37,814 cases and 
4,403 deaths. In the United Kingdom there were, among 66.65 
million inhabitants, around 290,000 cases and 41,128 fatalities, 
and in the USA these data were 328.2 million, 2.04 million, 
115,000 deaths.  
This overview of strategies confirms that, as said in the 
introduction, the results depend indeed heavily on the state of 
Public Health. Note that nowadays in every language of the world 
the concept "Public Health" is designated by a literal translation or 
a slight modification of this expression. For instance in Danish it is 
"folkesundhed", that is, "Health of the People". 
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TOP-DOWN 
In this second part we shall sketch the scientific and in particular 
mathematical principles involved in the study of successive stages 
of the pandemics. In short: Sect. 4: Discovery of the new virus, 
basic properties, testing for its presence in a person. 5 and 6: Data 
on the evolution of Covid-19 in a population. 7: Attempts at 
analysing mathematically and predicting such an evolution by 
representing it by an epidemic curve. 8: The analogous for a 
representation by a compartmental model. 9: Trying to stop the 
epidemic by a vaccine. 10: What to learn and what to do?  
4. The New Virus SARS-CoV-2 
After the often-depicted outbreak in late December 2019 of cases 
of pneumonia of unknown aetiology around Wuhan, in the course 
of January 2020 Chinese scientists identified a new virus as the 
pathogen. They followed the usual procedures, i.e., they 
determined the load of 26 common respiratory pathogens in the 
patients. They found none of them in abundance. They suspected 
SARS-CoV but could not find it either. Then they investigated all 
kinds of viral load that had a slight similarity (coincidence in a 
number of genomes) with SARS-CoV and detected a novel virus 
which displayed abundant virions in respiratory specimens from 
patients. Electron microscopy and mathematical pattern analysis 
[MUM, PEV] showed that it belongs to the same species as SARS-
CoV-1  and MERS-CoV (Sect. 2); hence the name SARS-CoV-2. 
Starting with this work in China a large number of publications 
about the peculiar properties of the pathogen and the ways it is 
acting have appeared. On the virological side its genetic sequence 
was determined. The new virus is believed to have zoonotic origins 
but human to human infection was rapidly established. The 
combination of SARS and Influenza features, that is intensive 
respiratory inhibition of patients and rapid transmission, make 
Covid-19, the disease caused by SARS-CoV-2, particularly 
dangerous. For further work see [AND]. 
In the clinical context, several periods in the evolution of a case 
were determined (see their definition in [KPP, Sect. 5.2]): The 
median incubation period is 5.2 days; the mean latency period is 
4.6 days, i.e., in general the infectious period starts indeed before 
the prodromal phase. We have discussed the implications in Sect. 
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2 by comparison with Ebola. The mean length of the infectious 
period is 6 days for mild and asymptomatic cases; for severe and 
critical cases this period lasts on the average 22 days and ends 
only by recovery or death. 
The manifold applications to the control of the pandemic of both 
their virological and their clinical characteristics will appear in 
Sects. 7, 8, 9 and 10. Their study is still active and may even 
reverse former results; this happened for example recently about 
so-called cross-immunities. However, in this article we shall only 
treat applications to the basic element of well-designed control 
strategies, namely testing for infections.  
The first step of a test programme is to define the target 
population. Who will be tested? Subjects who had a contact with 
infected people? Or those who complain about symptoms? Or 
everybody coming from a region where cases exist? See the 
example of Vietnam in Sect. 3. 
Next, what will be the objective? To discover the presence of the 
virus or that of some kind of antibodies? Depending on the 
objective there exist virological and serological tests. The usual 
virological test is called the PCR-(Polymerase Chain Reaction) Test. 
Dozens of serologic tests of varying quality have been and still are 
developed and even offered in some countries to the general 
public. Recall that the characterization of a test with a given target 
population and a given objective is a classical subject of clinical 
epidemiology [KPP, Sect. 19.2].  
Coming back to the fundamental role of testing in control 
strategies we only remark that in poor countries or in rich 
countries with inattentive public health officials, the target 
population was often determined by the shortage of test kits and 
by the influence of institutions that required them for themselves.  
5. Demography: Descriptive Epidemiology  
This is classical medical statistics, which gives for a specific disease 
the number of cases and deaths together with the when and 
where and a few additional data such as sex, age and sometimes 
profession of the subjects.  
Covid-19                  Booß-Bavnbek &Krickeberg, 17 august 2020                                                     14 
In principle the methods for finding the number of confirmed 
cases and of fatalities by Covid-19 are the same as for any other 
disease. They fluctuate widely between countries. Both the 
diagnosis of a case of a disease and the description of the cause of 
a death may be relatively correct or most unreliable. In particular 
finding a correct diagnosis for somebody who complains about 
acute health problems depends very much on the local contact 
tracing methods and on the state of the clinical-medical system. 
An additional difficulty arises form the existence of asymptomatic 
forms of the disease, that is, subjects infected by SARS-CoV-2 who 
display no symptoms.  
In Sect. 3 we have mentioned Vietnam, which uses its normal 
demographic and health information systems [KKR]. It includes in 
its statistics asymptomatic cases found by contact tracing. Other 
countries obtain their morbidity and mortality data from a "Health 
Reporting System". Such a system is partly based on sampling 
methods from various sources, for example hospitals and local 
health offices. In Germany the Robert Koch-Institute, a central 
institute mainly devoted to infectious diseases, reports on the 
results for Covid-19. In the USA the Johns Hopkins University plays 
a similar role. Still other countries use data from health insurance 
offices. 
However, many countries have neither a health information 
system nor a health reporting system, or they do not use it for 
Covid-19. A host of alternative methods is being employed. For 
example France counts only hospitalized confirmed cases and only 
deaths which happen in a hospital or in a retirement home that is 
connected with a medical structure. 
Summing up we may say that morbidity data and to a lesser 
degree mortality data for Covid-19 that one finds in various 
periodic publications are fairly unreliable, with very few exceptions. 
The sources are not always clearly indicated.  
An important alternative idea is to compare the present situation 
with that in years past. Speaking again naïvely we assume that the 
present higher case frequencies and death tolls, and only these, 
are the result of Covid-19. Given the diagnostic difficulties 
mentioned above this idea is mainly applied to fatalities and hardly 
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to nonlethal cases. Thus in the method of "excess mortality" we 
only measure how many more deaths by any cause happened this 
year than in the corresponding period in the past. For the UK we 
have for instance quoted in Sect. 3 the figure of 41,128 deaths up 
to the 1st June as supplied by the National Health Service. By 
contrast the National Statistical Office advanced about 62,000 
deaths as excess mortality!  
 
 
Fig. 2 Estimated number of infections on lock-down day and excess mortality 
for 16 selected countries. Reproduced from [FIT], permission granted by 
Financial Times Syndication 
Finally, here is an interesting idea based on the most classical form 
of a statistical-mathematical model. A graphic in the paper [FIT] 
(see Figure 2) shows for every one of 16 selected countries the 
point in the plane whose coordinates are, respectively, the 
estimated number of infections per million inhabitants on lock-
down day and the excess mortality. A short glance convinces us 
that they are positively correlated. A simple regression analysis 
based on this graphic would allow us to estimate one of these 
values by the other one for any other country, too.  
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6. Advanced Demography 
It goes in several directions beyond classical health statistics, all of 
them relevant to Covid-19, too. Firstly, sample surveys are 
conducted instead of using the data from the entire "target 
population". They have for example been used to study the 
influence of social factors on the evolution of various aspects of 
the disease. In particular the factor "to be an immigrant or to 
descend from them" was thoroughly investigated in some 
countries. Secondly, more types of data about cases and deaths 
are collected, for example about morbidity and mortality by age 
groups. Thirdly, data sets are not only being registered and 
perhaps published but also transformed and interpreted in various 
ways. Here, standardization is the best-known procedure. A 
fictitious example would be the number of fatalities by Covid-19 in 
Denmark if Denmark had the same age structure as Vietnam and 
in each age group it had the same Covid-19 mortality as in the 
same age group in Vietnam.  
In Sect. 9 we shall meet statistical-mathematical models as a basic 
mathematical tool in developing a preventive treatment of Covid-
19. With their help one studies in a clinical trial the influence of 
various factors on some outcome variable E of interest. Here the 
idea of "controlling" for the influence of another factor, which 
might be a "confounder" in the study of the action of E , plays a 
role. It looks as if most demographers on the one hand, and most 
clinical epidemiologists on the other, ignore that the mathematical 
procedure of standardizing is the same as that of controlling for a 
confounder [KPP, Lesson 21]. A mathematician will not be 
astonished, though! 
7. Modelling the Epidemic Curve 
We have mentioned this classical concept in Sect. 1; see [KPP, 
Sect. 4.6]. Let C be an epidemic, V a geographical region, t0  a 
moment of time which may be that of the first case of C in V , and 
f(t) for t ≥ t0  the number of observed and reported cases of C that 
had declared themselves in V before or at the instant t . Then f  is 
called the epidemic curve of C in V . In particular it needs to be 
said whether unconfirmed cases are included or not. Measuring 
f(t) as the time t goes along is the task of the relevant 
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demographic services (Sects. 5 and 6). This process is therefore 
subject to all the deficiencies listed there.  
To get some knowledge about f  for various regions V  is of course 
one of the main concerns of the population of a country invaded 
by C . Such knowledge is equally vital for health authorities who 
attempt to control C . However, much more knowledge is 
desirable. What can we learn about the mechanism of C by 
observing f(t) ? This was already the subject of the papers 
described in [FIN]; see Sect. 1. In particular, is there a way to 
predict aspects of the future evolution of f , having observed the 
values f(t) for a while?  
Answers to these questions are generally given by modelling f , 
that is by making certain assumptions about its shape and by 
estimating certain parameters in it. A very large number of papers 
was published about this issue. Some of them use extrapolation 
methods known from mathematical economy. A recent survey on 
basic ideas and techniques can be found in [KRM] where a model 
is described in terms of an integro-differential equation.  
We shall restrict ourselves to a discussion of an application, 
namely the so-called basic reproduction number R0 . It appears 
constantly in popular publications. To define it let us look at a 
subject s that is infected at a time t* ≥ t0  . Let µ(s, t*) be the 
number of all subjects infected by s after t* in the form of 
secondary, tertiary etc. infections. Then R0 is the average of µ(s, 
t*) over all s . Thus it depends on t*. It is precisely this 
dependence in which people are interested: a value less than 1 is 
looked upon as predictor of the extinction of C after t*. In the case 
C = Covid-19, values as high as 5.7 had been estimated in the 
beginning, that is, for t* close to the time of the first outbreak of 
C. The article [SIA] presents an interesting factorisation of R0  in 
order to compare different approaches to control the size of it.   
8. Compartmental Models 
We have sketched their historical origin in Sect. 1. We   
distinguished between two ways of mathematically modelling the 
evolution of an epidemic. Models of the first kind (Sect. 7) 
represent the temporal evolution of the number of subjects in a 
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certain state, for instance the state "to be infected". By contrast, 
compartmental models also represent changes of this state at 
some moments in the form of transitions of a subject from one 
compartment to another one.  
The SIR-model, which we designated in Sect. 1 as "intensively 
studied in the 1920s", is particularly simple and has served as a 
paragon for many others, in particular for those applied to Covid-
19. It involves three compartments: S are the susceptible, not yet 
infected subjects, I the infected ones, and R consists of subjects 
removed by recovery with immunity or death. The transitions 
between compartments are described by differential equations for 
the numbers S(t), I(t) and R(t) of subjects in the compartments as 
a function of time t . They involve certain parameters such as 
transition probabilities from one compartment to another one. 
Under various assumptions the resulting system of differential 
equations for S , I and R can be solved explicitly or numerically. 
A first important application is to estimate the basic reproduction 
number R0 defined in Sect. 7. It can be expressed by the basic 
parameters.  
Secondly, it turns out that the limit S∞ of S(t) for 
 
t →∞  is strictly 
positive, which means that a certain part of the population will 
never be infected. This led to the concept of herd immunity, 
which, however, gave rise to much confusion among people who 
thought they had something to say about the matter. 
After the outbreak of Covid-19 many more involved 
compartmental models were defined and analysed. Their 
parameters represented among other features the underlying 
control strategy to be used. There was for instance the "do 
nothing" strategy and also the "mitigation" strategy, which 
consisted of the less stringent components of the "surveillance-
containment strategy" defined in Sect. 3. In the much discussed 
paper [FER] Neil Ferguson and collaborators described the shape 
of the function I, that is the number of infected subjects, for the 
"do nothing" strategy. From the value 0 on it increases, reaches a 
maximum, decreases and finally reaches 0 at a certain moment 
thappy . This had apparently motivated the countries UK, USA, 
Sweden and Brazil to adopt this strategy for too long, ignoring that 
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Ferguson predicted (see Figure 3) about 500,000 deaths caused 
by the epidemic in the UK and 2.2 million in the USA before 
extinction at the moment thappy.  
 
Fig. 3 Expected deaths caused by the epidemic for the do-nothing strategy, 
reproduced from [FER] with permission of School of Public Health, Imperial 
College London 
 
At present compartmental models play hardly any practical role, 
mainly because they contain too many unknown parameters.  
Some parameters such as infectivity are estimated with the help of 
a model of the epidemic curve, which seems to be a not very 
successful detour.  
9. Preventive and Curative Treatments 
It will hardly surprise that several pharmacological companies have 
started a run for developing curative and preventive treatments of 
various ailments, which SARS-CoV-2 may inflict on a person. Up to 
now no curative treatment was found. There are only the well-
known methods to be used in the treatment of non-specific 
aspects of a case such as reducing pain, facilitate breathing or 
shorten the time to recovery by a antiviral drug. We shall therefore 
restrict ourselves to preventive treatments, that is, to 
immunizations. 
The objective of an immunization by a vaccine against a Covid-19 
connected health deficiency needs to be defined in the same way 
Covid-19                  Booß-Bavnbek &Krickeberg, 17 august 2020                                                     20 
as for any other infectious disease. First the target population 
needs to be determined: whom do we intend to protect? Next, 
what are the health deficiencies we want to prevent? For how long 
is the preventive effect to last? This is a particularly important 
aspect of the vaccine but is usually suppressed when a new one is 
announced. For instance the measles vaccination remains lifelong 
active in most subjects. For Covid-19 the company which tries to 
develop the vaccine may be satisfied with a few months, hoping 
that SARS-CoV-2 will have disappeared after that. Finally the 
efficacy needs to be found, which represents the part of the target 
population actually protected. It may also be defined in 
epidemiologic terms by regarding as "exposed" all subjects that 
had not obtained the treatment. Then the efficacy is the 
"aetiological fraction among the exposed subjects". 
Nowadays there is general agreement that the process of 
developing a vaccine against an infectious disease needs to run 
along a well-defined common line [KPP, Lesson 18, and HAL]. This 
ought to hold for Covid-19, too, and we shall therefore recall it 
here.  
First, one or several substances are selected which, for some 
reasons whatsoever, usually virological ones, look like possible 
candidates for a vaccine. Each of them needs to be submitted to a 
"clinical trial" in order to explore its most important properties. 
Such a clinical trial consists of three "phases" I, II and III. Phase I 
deals with various mainly pharmacologic aspects such as side 
effects for various possible dosages.  
Statistical-mathematical models are the essential tools of the 
phases II and III. Phase II aims at providing a first idea of the 
efficacy of the selected vaccine. Thus a relatively small target 
population is built artificially. Here two basic problems arise. The 
first is the definition of the outcome variable of interest. Often only 
the "immunogenicity" is being studied, which means the formation 
of antibodies, but not protection against the disease. It is a 
particularly complex and manifold problem in the case of Covid-19. 
Secondly, the target population needs to include among the 
vaccinated subjects a sufficient number of people who would 
attract the disease when not vaccinated. Since Covid-19 morbidity 
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in the entire population of a country is small, such a group must 
be constructed by "challenge", that is, by infecting its members 
artificially. They are usually volunteers and their risk of dying is 
small except in the age groups where the lethality by the disease 
is high, that is, in the case of Covid-19, for old people. Faced with 
this ethical problem the USA used, for various previous infectious 
diseases, prison inmates whose terms were shortened as a 
reward. There was a time when Vietnam, while developing a 
certain vaccine, sent its samples for the Phase II trial to the USA 
to be tested in this way because Vietnamese ethical standards 
forbade all kinds of challenge. 
There are usually several phase II trials in order to select the 
potential vaccine to be finally studied in a phase III trial. This is a 
field trial in the sense that a sample of subjects is drawn from the 
entire population of interest, for instance from among all 
inhabitants of a country within a certain age group. The outcome 
variable is not immunogenicity but protection against the disease 
in the sense of the desired efficacy. The size of the sample is 
determined beforehand by the precision of the intended estimate 
of the efficacy. As noted above the decision about the duration of 
the trial is a crucial element. If high efficacy during the first two 
weeks after vaccination is considered sufficient, the trial may be 
stopped after two weeks; this philosophy underlies the 
vaccinations against the seasonal influenza. If we are interested in 
its efficacy during the first ten years after vaccination, it must last 
ten years. This has, in addition to other problems, caused the long 
delay in developing an Ebola vaccine (end of Sect. 2). We hope 
that it will not be glossed over by those who are trying to sell a 
Covid-19 vaccine very soon. 
10.  Outlook 
The pandemic has functioned like a magnifying glass. In some 
places, it showed a basically well-functioning society. In other 
places it revealed scandals and intolerable social inequalities. In 
particular it reflected the state of a country’s public health system. 
The present article aimed at describing the role of mathematics in 
the pandemic. As said above there are two parts to this "outlook". 
Let us take up the first one, namely: What can be learnt from the 
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epidemic? In Sect. 1 we gave an overview of the main branches of 
mathematics that play a role. Then the Sects. 4 - 9 sketched the 
most frequent applications; their titles and their order correspond 
vaguely to the branches of mathematics concerned. Thus there 
were mathematical pattern analysis in laboratory work and 
statistical-mathematical models in judging the quality of tests; 
demographic methods in the collection of data; different ways to 
model the evolution of the pandemic mathematically; and clinical 
epidemiology in attempts to develop a vaccine.  
In this way the article aimed at clarifying the potential role of 
mathematics in making decisions. On the one hand it turned out 
that in practise the role of epidemic curve or compartmental 
models is much more restricted than advertised in many 
publications. Decisions based on them may even have disastrous 
consequences, for instance those based on the mathematical 
concept of herd immunity. Thus blind trust in mathematical 
arguments is unjustified.  
On the other hand denying the existence of a valid mathematical-
scientific foundation for a control strategy is just as detrimental. It 
was done in Denmark with the "tracing and lock-down" strategy 
by a report of an "expert group" of health academics and officials, 
which reflected the interests of medical, industrial and 
governmental circles.  
This comment leads us to the second part of our "outlook", 
namely: What to do in the future? The authors of the present 
article started it in early May by "Since the Covid-19 pandemic is 
not over ...". While we are finally finishing our work in the middle 
of July, it is still not over! It is even very active but has taken a 
largely different form. Hence it seems natural to analyse its 
present characteristics in the light of the facts we have described 
in the Sections 4 - 9 above and to ask ourselves: which lessons 
can we draw regarding the control strategies to be applied now? 
Covid-19 does no longer surge from a single source. It reappears 
in small or large regions of many parts of the world, which may be 
of various forms and extensions: a single home for the elderly in 
France, two districts in Germany, a large city like Beijing, an entire 
province in Spain, or a whole country like New Zealand. We shall 
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call them "nests" to distinguish them from "clusters", which denote 
certain discrete sets of people. A precise follow-up of the evolution 
of cases in these nests meets with the manifold difficulties 
explained in Sects. 5 and 6 and will not be repeated here.  
A first natural question to ask is, then: why do "active" nests 
persist and reappear? Sect. 3 presented three components of 
successful control strategies: contact tracing; lock-down; masks. 
While contact tracing continues reluctantly, lock-down and wearing 
masks were widely abandoned, often as a result of governmental 
policies seeking popularity.  
Next, what should be done? In the Sections 7, 8 and 9 we have 
explained, using in particular mathematical arguments, in how far 
the strategies of control treated there suffer from serious 
drawbacks. This leaves us with the combination of two measures: 
inside a nest a rigorous lock-down such as social distancing and 
preventing larger assemblies of people; at its borders: closing 
them or only allowing passage when combined with quarantine. 
For example New Zealand regarded as a single nest has taken 
such rigorous measures. As a result there are now no new cases, 
except two cases around the 14th July in "managed isolation 
facilities". Other nests will act similarly, we hope. 
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